New Key Statistics Module, Z-Score and F-Score
NAS:URGN Key Ratios
| Market Cap $ M | 473.06 |
| Enterprise Value $ M | 323.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 18.38 |
| Price/Sales | 4.51 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 89.00 |
| EPS (TTM) $ | -3.09 |
| Beneish M-Score | -2.02 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 9.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.27 |
| EV-to-EBITDA | -3.31 |
| PEG | -- |
| Shares Outstanding M | 42.20 |
| Net Margin (%) | -129.11 |
| Operating Margin % | -93.70 |
| Pre-tax Margin (%) | -124.59 |
| Quick Ratio | 8.77 |
| Current Ratio | 9.00 |
| ROA % (ttm) | -49.89 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -347.06 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.33 |
URGN Number of Guru Trades
URGN Volume of Guru Trades
Gurus Latest Trades with NAS:URGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:URGN is held by these investors
Total 1
UroGen Pharma Ltd Insider Transactions
No Available Data
News about NAS:URGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers